School Seminar Program
All are welcome and no RSVP is required.
Usual time: Wednesdays, 12pm–1pm
Usual venue: Monash Public Health and Preventive Medicine, Ground Floor Conference Rooms, 553 St Kilda Road, Melbourne 3004
Enquiries: Professor Anita Wluka via email or SPHPM Reception +61 3 9903 0444
Please check back close to the dates below for any changes to the schedule.
|Chad Brummett, MD|
Associate Professor, Anesthesiology; Director, Anesthesia Clinical Research; Director, Division of Pain Research, University of Michigan (USA)
|The role of acute care prescribing in the opioid epidemic|
|Professor Robin Haring|
Professor of Comparative Health Sciences, European University of Applied Sciences (Germany)
|Associations between trial characteristics and treatment effects in randomized trials of testosterone therapy in men: meta-epidemiological study|
|Dr Debbie Marais|
Director of Postgraduate Education, Warwick Medical Sschool, University of Warwick (UK)
|AGILe curricula to enhance employability|
Enhancing employability is key to HE and we can do this if we ensure our curriculum includes opportunities for learning and assessment that is Authentic, develops Global citizenship and encourages Interdisciplinary Learning.
|Professor Declan Devane |
Director, Evidence Synthesis Ireland and Cochrane Ireland
** NOTE: TUESDAY, 12pm–1pm **
|When children and the public become chief investigators for randomised trials|
Randomised trials are instrumental in providing reliable and robust evidence on the benefits, harms and costs of health care, so that people can make informed choices. However, the general public’s understanding of randomised trials can be limited and ensuring public support for and participation in trials remains challenging. Using examples from the ‘Schools Teaching Awareness of Randomised Trials (START)’ program and The People’s Trial, Prof Devane will describe some of the work of the Health Research Board-Trials Methodology Research Network (Ireland) in involving the public in the design, conduct, analysis, reporting and dissemination of randomised trials. These initiatives not only enhance the public under-standing of randomised trials but provide an opportunity for sharing learning around what works best to involve the public in all steps of a trial process. This is vital in an era of growing concerns about the conduct of poor research, the relevance of research to end-users and the cost of research waste.